1-3 of 3
Oliver Weigert
Close
Sort by
Journal Articles

The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas

Itziar Salaverria, Oliver Weigert, Leticia Quintanilla-Martinez
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5258–5271.
https://doi.org/10.1182/bloodadvances.2022009456
Published: 2023
Journal Articles

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Clinical Trials & Observations
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, Sarah Haebe, Verena Passerini, Johannes C. Hellmuth, Erik Gaitzsch, William Keay, Natyra Tahiri, Anna Zoellner, Andreas Rosenwald, Wolfram Klapper, Harald Stein, Alfred Feller, German Ott, Annette M. Staiger, Heike Horn, Martin L. Hansmann, Christiane Pott, Michael Unterhalt, Christian Schmidt, Martin Dreyling, Ash A. Alizadeh, Wolfgang Hiddemann, Eva Hoster, Oliver Weigert
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4451–4462.
https://doi.org/10.1182/bloodadvances.2020002546
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of age on clinical risk scores in follicular lymphoma

Clinical Trials & Observations
Stefan Alig, Vindi Jurinovic, Alessandro Pastore, Sarah Haebe, Christian Schmidt, Anna-Katharina Zoellner, Martin Dreyling, Michael Unterhalt, Eva Hoster, Wolfgang Hiddemann, Oliver Weigert
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1033–1038.
https://doi.org/10.1182/bloodadvances.2019032136
Published: 2019
Includes: Supplemental data